AVITA Medical
RCEL
AVITA Medical (RCEL) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.25
- EPS estimate
- −$0.29
- EPS surprise
- +14.62%
- Revenue surprise
- +6.12%
- Revenue
- $21.5M
- Revenue estimate
- $20.3M
- Reported
- Aug 6, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | −$0.29 | −$0.25 | +14.62% | $21.5M | SEC |
| Q1 2026 | May 14, 2026 | −$0.29 | −$0.35 | −19.86% | $19.3M | SEC |
| Q4 2025 | Feb 12, 2026 | −$0.36 | −$0.38 | −4.28% | $17.4M | SEC |
| Q3 2025 | Nov 6, 2025 | −$0.33 | −$0.46 | −38.60% | $17.1M | SEC |
| Q2 2025 | Aug 7, 2025 | −$0.25 | −$0.38 | −52.00% | $18.4M | SEC |
| Q1 2025 | May 8, 2025 | −$0.32 | −$0.53 | −64.04% | $18.5M | SEC |
| Q4 2024 | Feb 13, 2025 | −$0.45 | −$0.44 | +1.50% | $18.2M | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.45 | −$0.62 | −38.67% | $19.5M | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.50 | −$0.60 | −20.89% | $15.2M | SEC |
| Q1 2024 | May 13, 2024 | −$0.48 | −$0.73 | −52.62% | $11.1M | SEC |
| Q4 2023 | Feb 22, 2024 | −$0.39 | −$0.28 | +28.99% | $14.2M | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.44 | −$0.34 | +21.89% | $13.6M | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.31 | −$0.41 | −30.91% | $11.8M | SEC |
| Q1 2023 | May 11, 2023 | −$0.27 | −$0.37 | −36.94% | $10.6M | SEC |
| Q4 2022 | Feb 23, 2023 | −$0.24 | −$0.21 | +13.26% | $9.5M | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.33 | −$0.22 | +33.57% | $9.1M | SEC |
| Q2 2022 | Aug 11, 2022 | −$0.34 | −$0.25 | +27.16% | $8.3M | SEC |
| Q4 2021 | Feb 28, 2022 | −$0.29 | −$0.19 | +34.93% | $10.3M | SEC |
| Q1 2022 | May 12, 2022 | −$0.35 | −$0.38 | −9.10% | $7.5M | SEC |
| Q3 2021 | May 13, 2021 | −$0.35 | −$0.26 | +25.74% | $8.8M | SEC |
Quarterly revenue
Frequently asked questions
When did AVITA Medical (RCEL) last report earnings?
AVITA Medical last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did RCEL beat earnings estimates?
Yes. AVITA Medical reported EPS of −$0.25 for Q2 2026 against a −$0.29 estimate — a 14.62% beat.
How much revenue did RCEL report last quarter?
AVITA Medical reported $21.5M in revenue for Q2 2026, against a consensus estimate of $20.3M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.